Xentuzumab, CAS 1417158-65-6

Product Description: Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) is a recombinant a human monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Weyer-Czernilofsky U, et al. Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer Models. Mol Cancer Ther. 2020 Apr;19(4):1059-1069.

CAS Number: 1417158-65-6

Molecular Weight: N/A

Compound Purity: 99.71

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: IGF-1R

• Artikelnummer: MEXHY-P99274-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99274-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK